Stock Symbol:

ITMN

Company Name:

InterMune, Inc.

Company Description:

InterMune, Inc., a biotech company, focuses on developing and commercializing therapies in pulmonology and hepatology primarily in the United States and Europe.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

J-A-J-O

Stock Exchange:

NASDAQ

Predicted Split Price:

$57.00

Predicted Split Ratio:

3 for 2

5 Day Performance After Split:

4.1%

Prior Stock Splits:

0

Stock Split History:

None

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.